Publisher's Synopsis
Eight presentations explore the potential for the use of immunomodulatory therapies to treat inflammatory rheumatic diseases, which are inadequately controlled by existing therapies. They outline and critically review some new or particularly potent therapies, such as methotrexate, azathioprine, alk